X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (925) 925
Publication (40) 40
Newsletter (37) 37
Book Chapter (16) 16
Book Review (9) 9
Magazine Article (8) 8
Dissertation (3) 3
Book / eBook (2) 2
Trade Publication Article (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (751) 751
dermatology (455) 455
index medicus (443) 443
actinic keratosis (420) 420
female (336) 336
male (333) 333
aged (273) 273
middle aged (266) 266
squamous cell carcinoma (252) 252
skin (223) 223
skin neoplasms - pathology (221) 221
keratosis (211) 211
skin cancer (197) 197
cancer (192) 192
adult (175) 175
squamous-cell carcinoma (167) 167
carcinoma, squamous cell - pathology (156) 156
skin neoplasms - genetics (147) 147
aged, 80 and over (143) 143
care and treatment (131) 131
carcinoma, squamous cell - genetics (128) 128
keratosis - pathology (127) 127
keratosis, actinic - pathology (108) 108
oncology (105) 105
keratosis - genetics (98) 98
immunohistochemistry (95) 95
keratosis, actinic - drug therapy (92) 92
animals (91) 91
melanoma (90) 90
risk factors (88) 88
nonmelanoma skin-cancer (87) 87
research (85) 85
skin neoplasms - metabolism (85) 85
tumors (84) 84
diagnosis (83) 83
photodynamic therapy (83) 83
analysis (81) 81
skin neoplasms - etiology (80) 80
pathology (79) 79
skin - pathology (78) 78
basal cell carcinoma (72) 72
ultraviolet rays - adverse effects (71) 71
cell biology (70) 70
carcinoma, squamous cell - metabolism (67) 67
mutation (62) 62
skin-cancer (62) 62
sunlight - adverse effects (62) 62
carcinoma, basal cell - pathology (61) 61
lesions (61) 61
expression (60) 60
biopsy (59) 59
solar keratoses (59) 59
mice (58) 58
genetic aspects (57) 57
prevalence (57) 57
actinic keratoses (55) 55
disease progression (55) 55
skin neoplasms - drug therapy (55) 55
keratosis, actinic - genetics (54) 54
dna (53) 53
skin neoplasms - diagnosis (52) 52
apoptosis (51) 51
basal-cell carcinoma (51) 51
carcinoma, squamous cell - etiology (51) 51
photochemotherapy (51) 51
treatment outcome (51) 51
development and progression (50) 50
skin neoplasms - prevention & control (50) 50
double-blind (49) 49
health aspects (49) 49
skin diseases (49) 49
keratosis - etiology (48) 48
medicine (48) 48
p53 (46) 46
skin neoplasms - epidemiology (46) 46
molecular biology (45) 45
biochemistry (44) 44
precancerous conditions - pathology (44) 44
diagnosis, differential (43) 43
imiquimod (43) 43
keratosis, actinic - diagnosis (43) 43
medicine & public health (43) 43
gene expression (42) 42
keratosis - metabolism (42) 42
keratosis - drug therapy (41) 41
skin - metabolism (41) 41
solar keratosis (41) 41
adolescent (40) 40
biochemistry & molecular biology (40) 40
keratinocytes - pathology (40) 40
keratosis, actinic (40) 40
carcinoma (39) 39
carcinoma, basal cell - genetics (39) 39
polymerase chain reaction (39) 39
administration, topical (38) 38
case-control studies (38) 38
keratosis, actinic - metabolism (38) 38
medical research (38) 38
keratinocytes (37) 37
mutations (37) 37
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (952) 952
German (15) 15
French (11) 11
Polish (2) 2
Russian (2) 2
Spanish (2) 2
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Cancer, ISSN 0007-0920, 01/2014, Volume 110, Issue 2, pp. 520 - 529
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 01/2017, Volume 127, Issue 1, pp. 106 - 116
BACKGROUND. Actinic keratosis is a precursor to cutaneous squamous cell carcinoma. Long treatment durations and severe side effects have limited the efficacy... 
2.5-PERCENT | MEDICINE, RESEARCH & EXPERIMENTAL | ATOPIC-DERMATITIS | KERATINOCYTES | ACTINIC KERATOSES | INDUCTION | FACE | THYMIC STROMAL LYMPHOPOIETIN | VITAMIN-D3 | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Skin Neoplasms - drug therapy | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | CD4-Positive T-Lymphocytes - pathology | CD4-Positive T-Lymphocytes - immunology | Precancerous Conditions - drug therapy | Calcitriol - administration & dosage | Calcitriol - analogs & derivatives | Fluorouracil - administration & dosage | Immunity, Cellular - drug effects | Keratosis, Actinic - genetics | Aged, 80 and over | Female | Precancerous Conditions - pathology | Keratosis, Actinic - immunology | Cytokines - genetics | Cytokines - immunology | Skin Neoplasms - pathology | Immunity, Cellular - genetics | Skin Neoplasms - immunology | Mice, Transgenic | Carcinoma, Squamous Cell - immunology | Precancerous Conditions - genetics | Animals | Carcinoma, Squamous Cell - drug therapy | Precancerous Conditions - immunology | Keratosis, Actinic - drug therapy | Skin Neoplasms - genetics | Aged | Mice | Administration, Topical | Keratosis, Actinic - pathology | Actinic keratosis | Care and treatment | Usage | Clinical trials | Dosage and administration | Calcipotriene | Fluorouracil | Psoriasis | Rodents | Immunotherapy | Genetic engineering | Inflammation | Tumors | Skin cancer | Index Medicus | Abridged Index Medicus
Journal Article
BMC Cancer, ISSN 1471-2407, 02/2013, Volume 13, Issue 1, p. 58
Journal Article
PLoS Pathogens, ISSN 1553-7366, 07/2011, Volume 7, Issue 7, p. e1002125
Cutaneous beta human papillomavirus (HPV) types appear to be involved in the development of non-melanoma skin cancer (NMSC); however, it is not entirely clear... 
HUMAN-PAPILLOMAVIRUS TYPE-38 | MICROBIOLOGY | RENAL-TRANSPLANT RECIPIENTS | CARCINOGENESIS | VIROLOGY | NONMELANOMA SKIN-CANCER | DNA | GENES | INFECTION | PROTEINS | PARASITOLOGY | TRANSGENIC MICE | BASAL-CELL | Tetradecanoylphorbol Acetate - adverse effects | Tetradecanoylphorbol Acetate - pharmacology | Keratinocytes - virology | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | 9,10-Dimethyl-1,2-benzanthracene - pharmacology | Epidermis - virology | Papillomavirus Infections - pathology | Carcinogens - pharmacology | Cyclin-Dependent Kinase Inhibitor p21 - genetics | Keratosis, Actinic - genetics | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Oncogene Proteins, Viral - genetics | Skin Neoplasms - pathology | Epidermis - metabolism | Epidermis - pathology | Mice, Transgenic | Oncogene Proteins, Viral - biosynthesis | Ultraviolet Rays - adverse effects | Papillomavirus Infections - genetics | Skin Neoplasms - metabolism | Alphapapillomavirus | Carcinoma, Squamous Cell - etiology | Keratinocytes - pathology | Animals | Keratinocytes - metabolism | Papillomavirus Infections - metabolism | Skin Neoplasms - genetics | Skin Neoplasms - virology | Keratosis, Actinic - virology | Keratosis, Actinic - metabolism | Mice | Skin Neoplasms - etiology | Keratosis, Actinic - pathology | 9,10-Dimethyl-1,2-benzanthracene - adverse effects | Papillomaviruses | Actinic keratosis | Squamous cell carcinoma | Ultraviolet radiation | Physiological aspects | Research | Tumor proteins | Health aspects | Risk factors | Studies | Human papillomavirus | Statistical analysis | Rodents | Experiments | Cervical cancer | Skin cancer | Tumors
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 06/2017, Volume 31, Issue 6, pp. 1038 - 1043
Journal Article
Clinical and Experimental Dermatology, ISSN 0307-6938, 04/2015, Volume 40, Issue 3, pp. 318 - 323
Summary Background Mutations of the EVER1 and EVER2 genes cause epidermodysplasia verruciformis (EV), a genodermatosis associated with squamous cell carcinoma... 
PAPILLOMAVIRUSES | GROWTH-FACTOR RECEPTOR | SQUAMOUS-CELL CARCINOMAS | PROGRESSION | EGFR | DERMATOLOGY | Multivariate Analysis | Membrane Proteins - genetics | Gene Frequency | Humans | Middle Aged | Genotype | Male | Case-Control Studies | Polymorphism, Genetic | Keratosis, Actinic - genetics | Aged, 80 and over | Female | Aged
Journal Article
Skin Pharmacology and Physiology, ISSN 1660-5527, 10/2015, Volume 28, Issue 6, pp. 281 - 289
Journal Article